Manufacturing Collaboration Stream

(Speculation Only But Continue Reading)

If IDT is unsuccessful with the Australian Government's Approach To Market (ATM), I believe it is IDT's intention to use the Manufacturing Collaboration Stream (MCS) to develop a mRNA manufacturing facility to support national vaccine research and creation.

Please do your own research into the MCS but this will provide IDT with sufficient funding to develop a facility and manufacturing and research ecosystem which is the sole purpose of this grant scheme.

Many people have overlooked this grant and are focusing on the ATM being the only way IDT can have the ability to manufacture mRNA vaccines